Combined plasma exchange and platelet transfusion in immune-mediated thrombocytopenic emergencies

被引:9
作者
Finn, Laura [1 ]
Tun, Han [1 ]
机构
[1] Mayo Clin, Jacksonville, FL 32224 USA
关键词
Immune mediated thrombocytopenia; Plasma exchange; PURPURA; THERAPY;
D O I
10.1016/j.transci.2013.06.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Refractory immune-mediated thrombocytopenia (ITP) can be very difficult to manage, especially if associated with a hemorrhagic or surgical emergency. We report two cases of refractory ITP that were unresponsive to routine therapeutic interventions and frequent platelet transfusions. A combination of plasma exchange and platelet transfusion successfully raised the platelet count to a level that permitted life-saving surgical interventions. Plasma exchange in these two cases likely reduced platelet antibodies significantly, decreasing platelet destruction. We propose that a trial of combination plasma exchange and platelet transfusion can be attempted in emergent thrombocytopenic situations with an underlying immune mechanism. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:661 / 664
页数:4
相关论文
共 10 条
  • [1] INTENSIVE PLASMA-EXCHANGE THERAPY IN 10 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
    BLANCHETTE, VS
    HOGAN, VA
    MCCOMBIE, NE
    DROUIN, J
    BORMANIS, JD
    TAYLOR, R
    ROCK, GA
    [J]. TRANSFUSION, 1984, 24 (05) : 388 - 394
  • [2] The Canadian experience using plasma exchange for immune thrombocytopenic purpura
    Buskard, N
    Rock, G
    Nair, R
    [J]. TRANSFUSION SCIENCE, 1998, 19 (03): : 295 - 300
  • [3] Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
    Chouhan, Jyoti D.
    Herrington, Jon D.
    [J]. PHARMACOTHERAPY, 2010, 30 (07): : 666 - 683
  • [4] ONE-YEAR FOLLOW-UP OF PLASMA-EXCHANGE THERAPY IN 14 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
    MARDER, VJ
    NUSBACHER, J
    ANDERSON, FW
    [J]. TRANSFUSION, 1981, 21 (03) : 291 - 298
  • [5] Plasma exchanges as treatment of severe acute immune thrombocytopenic purpura
    Masseau, A
    Guitton, C
    Bretonnière, C
    Renard, B
    Villers, D
    Hamidou, M
    [J]. REVUE DE MEDECINE INTERNE, 2005, 26 (10): : 824 - 826
  • [6] Nakhoul Ibrahim N, 2006, Clin Adv Hematol Oncol, V4, P136
  • [7] New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura
    Nurden, Alan T.
    Viallard, Jean-Francois
    Nurden, Paquita
    [J]. LANCET, 2009, 373 (9674) : 1562 - 1569
  • [8] International consensus report on the investigation and management of primary immune thrombocytopenia
    Provan, Drew
    Stasi, Roberto
    Newland, Adrian C.
    Blanchette, Victor S.
    Bolton-Maggs, Paula
    Bussel, James B.
    Chong, Beng H.
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Godeau, Bertrand
    Grainger, John
    Greer, Ian
    Hunt, Beverley J.
    Imbach, Paul A.
    Lyons, Gordon
    McMillan, Robert
    Rodeghiero, Francesco
    Sanz, Miguel A.
    Tarantino, Michael
    Watson, Shirley
    Young, Joan
    Kuter, David J.
    [J]. BLOOD, 2010, 115 (02) : 168 - 186
  • [9] PLASMA-EXCHANGE IN IDIOPATHIC THROMBOCYTOPENIC PURPURA
    WEIR, AB
    POON, MC
    MCGOWAN, EI
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (08) : 1101 - 1103
  • [10] Williams C, 1990, CURR STUD HEMATOL BL, V57, P131